Concepedia

Cihangir Duy

CD

Statistics

Publications

19

Citations

2.4K

H-Index

18

Active since

2005

Affiliations

Cornell University(Current)

Max Planck Institute of Immunobiology and Epigenetics

University of Southern California

Weill Cornell Medicine

Children's Hospital of Los Angeles

Cihangir Duy is an author at Cornell University specializing in molecular oncology, life sciences, and molecular biology.

ORCID

Publications per year

2005–2025

19

Publications

19

ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia

Tamara Maes, Cristina Mascaró, Iñigo Tirapu et al. · Cancer Cell · 2018 · 337 citations · Full text

, , +8

An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence

Eugen Dhimolea, Ricardo De Matos Simoes, Dhvanir Kansara et al. · Cancer Cell · 2021 · 262 citations · Full text

, , +12

Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence

Cihangir Duy, Meng Li, Matt Teater et al. · Cancer Discovery · 2021 · 255 citations · Full text

, , +17

BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition

Cihangir Duy, Christian Hurtz, Seyedmehdi Shojaee et al. · Nature · 2011 · 204 citations

, , +12

How Aggregation and Conformational Scrambling of Unfolded States Govern Fluorescence Emission Spectra

Cihangir Duy, Jörg Fitter · Biophysical Journal · 2006 · 173 citations · Full text

, , +12

1–5 of 19